Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs

BACKGROUND: Early initiation of combination antiretroviral therapy (cART), at higher CD4 cell counts, prevents disease progression and reduces sexual transmission of human immunodeficiency virus (HIV). We describe the temporal trends in CD4 cell counts at the start of cART in adults from low-income,...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848308/
https://www.ncbi.nlm.nih.gov/pubmed/29373672
http://dx.doi.org/10.1093/cid/cix915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848308/
https://www.ncbi.nlm.nih.gov/pubmed/29373672
http://dx.doi.org/10.1093/cid/cix915

Ejemplares similares